Почетна › Алцхајмерова болест › Kalifornija
Kliničke studije za Алцхајмерова болест u državi Kalifornija
50 studija za Алцхајмерова болест traži učesnike na lokacijama u državi Kalifornija.
Gradovi u državi Kalifornija
- Los Angeles14 студија
- Irvine12 студија
- San Diego11 студија
- Long Beach10 студија
- Anaheim9 студија
- San Francisco8 студија
- Orange7 студија
- Mountain View6 студија
- Oakland5 студија
- Concord5 студија
- Santa Ana4 студија
- Riverside4 студија
- San Bernardino3 студија
- Murrieta3 студија
- Burbank3 студија
- Chino3 студија
- Westminster3 студија
Zvanični tekst studije (na engleskom)
Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease
- Neurobehavioral Systems, Inc., Berkeley
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 89 · Оба пола · Ажурирано 13. 11. 2026. · NCT04800588A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Anaheim
- Clinical Site, Long Beach
- Clinical Site, Murrieta
- и још 3
Тражи се учесникФаза 2
Узраст од 55 до 90 · Оба пола · Ажурирано 12. 11. 2026. · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1657, Anaheim
- Local Institution - 1668, Fresno
- Local Institution - 2625, Long Beach
- и још 6
Тражи се учесникФаза 3
Узраст од 55 до 90 · Оба пола · Ажурирано 12. 11. 2026. · NCT06937229CMN LIFU for Enhanced Amyloid Reduction (CLEART Study)
- University of California San Francisco, San Francisco
Тражи се учесник
Узраст 65 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07866768A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Advanced Research Center (ARC) - Anaheim, Anaheim
- Local Institution - 1668, Fresno
- The Neurology Group, Pomona
- и још 1
Тражи се учесникФаза 3
Узраст од 55 до 90 · Оба пола · Ажурирано 6. 11. 2026. · NCT07011732A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- Healthy Brain Clinic- Site Number : 8400011, Long Beach
- Oakland Clinical- Site Number : 8400010, Oakland
Тражи се учесникФаза 2
Узраст од 55 до 85 · Оба пола · Ажурирано 6. 11. 2026. · NCT07688213A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
- Irvine Center for Clinical Research, Irvine
- Healthy Brain Clinic, Long Beach
- Inglewood Clinicals, Los Angeles
- и још 4
Тражи се учесникФаза 3
Узраст од 55 до 80 · Оба пола · Ажурирано 6. 11. 2026. · NCT07717411A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
- CenExel ACT, Anaheim
- Irvine Clinical Research, Irvine
- Collaborative Neuroscience Network - CNS, Los Alamitos
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 85 · Оба пола · Ажурирано 5. 11. 2026. · NCT07787169A Study of LY3439539 in Participants With Alzheimer's Disease
- Irvine Clinical Research, Irvine
- Healthy Brain Clinic, Long Beach
- Inglewood Clinical, Los Angeles
- и још 1
Тражи се учесникФаза 1
Узраст од 50 до 85 · Оба пола · Ажурирано 4. 11. 2026. · NCT07598370A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Profound Research LLC, Carlsbad
- Irvine Clinical Research, Irvine
- UCSD - Altman Clinical and Translational Research Institute (ACTRI), La Jolla
- и још 1
Тражи се учесникФаза 2
Узраст од 55 до 85 · Оба пола · Ажурирано 4. 11. 2026. · NCT07589595A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- National Institute of Clinical Research, Garden Grove
- Local Institution - 2607, Long Beach
- Accellacare, Long Beach
- и још 4
Тражи се учесникФаза 3
Узраст од 55 до 90 · Оба пола · Ажурирано 3. 11. 2026. · NCT07011745A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Advanced Research Center, Inc, Anaheim
- Sunwise Clinical Research, Walnut Creek
Тражи се учесникФаза 2
Узраст 55 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06540833A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Care Access - Huntington Beach, Huntington Beach
- Irvine Clinical Research, Irvine
- Healthy Brain Clinic, Long Beach
- и још 6
Тражи се учесникФаза 3
Узраст 55 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07602582A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Healthy Brain Clinic, Long Beach
- Anderson Clinical Research, Redlands
Тражи се учесникФаза 3
Узраст од 60 до 85 · Оба пола · Ажурирано 27. 10. 2026. · NCT06976216A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Advanced Research Center, Inc., Anaheim
- Inland Psychiatric Medical Group (IPMG)-Chino, Chino
- USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC), Los Angeles
Тражи се учесникФаза 3
Узраст од 55 до 90 · Оба пола · Ажурирано 27. 10. 2026. · NCT06585787Alzheimer's Tau Platform: Master Protocol
- University of California, San Francisco, San Francisco
Тражи се учесникФаза 2
Узраст од 50 до 80 · Оба пола · Ажурирано 26. 10. 2026. · NCT06957418[18F]PI-2620 Phase 3 Histopathological Study
- UC Los Angeles, Los Angeles
- Esperanza Clinical, Murrieta
- Sutter Health, San Francisco
Тражи се учесникФаза 3
Узраст 50 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT05641688A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease
- CenExel ACT, Anaheim
- Irvine Clinical Research, Irvine
- Collaborative Neuroscience Network - CNS, Los Alamitos
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 85 · Оба пола · Ажурирано 22. 10. 2026. · NCT07787182A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Irvine Clinical Research ( Site 1041), Irvine
- Healthy Brain Clinic ( Site 1005), Long Beach
- Inglewood Clinical ( Site 1062), Los Angeles
- и још 3
Тражи се учесникФаза 2
Узраст од 50 до 85 · Оба пола · Ажурирано 20. 10. 2026. · NCT07033494Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Sun Valley Research Center, Inc., Imperial
- Irvine Center for Clinical Research, Irvine
- Healthy Brain Clinic, Long Beach
- и још 5
Тражи се учесникФаза 3
Узраст од 50 до 90 · Оба пола · Ажурирано 19. 10. 2026. · NCT07177352A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Progeny Psychiatric Clinic - Irvine, Irvine
- ATP Clinical Research, Inc - Orange, Orange
Тражи се учесникФаза 4
Узраст 50 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT07633470Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study
- CSMC, Los Angeles
Тражи се учесник
Узраст од 55 до 89 · Оба пола · Ажурирано 13. 10. 2026. · NCT07224607A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Fullerton Neurology and Headache Center, Fullerton
- Irvine Clinical Research, Irvine
- Inglewood Clinical, Los Angeles
- и још 1
Тражи се учесникФаза 3
Узраст од 60 до 85 · Оба пола · Ажурирано 8. 10. 2026. · NCT06976203Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Esperanza Clinical, Murrieta
- Oakland Clinical Research, Oakland
- ATP Clinical Research, Inc., Orange
- и још 2
Тражи се учесникФаза 2
Узраст од 55 до 80 · Оба пола · Ажурирано 7. 10. 2026. · NCT06847321Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0017, Anaheim
- Inland Psychiatric Medical Group., Chino
- Kaizen Brain Center, La Jolla
- и још 2
Тражи се учесникФаза 2
Узраст од 55 до 90 · Оба пола · Ажурирано 6. 10. 2026. · NCT06808984A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
- CenExel ACT (Formerly Anaheim Clinical Trials; LLC), Anaheim
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 80 · Оба пола · Ажурирано 24. 9. 2026. · NCT07780383Predicting Pre-dementia
- Foster Carr MD, San Diego
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 55 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT07516119A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
- Irvine Center for Clinical Research /ID# 277752, Irvine
Тражи се учесникФаза 1/2
Узраст од 50 до 90 · Оба пола · Ажурирано 18. 9. 2026. · NCT07599670Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
- Saddleback Medical Center, Orange
Тражи се учесник
Узраст 70 и старији · Оба пола · Ажурирано 8. 9. 2026. · NCT05929703Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)
- UCLA TMS Clinical and Research Service, Los Angeles
Тражи се учесникФаза 1/2
Узраст од 55 до 100 · Оба пола · Ажурирано 4. 9. 2026. · NCT06597942Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
- Stanford Medical Center, Palo Alto
Тражи се учесник
Узраст 50 и старији · Оба пола · Ажурирано 24. 8. 2026. · NCT07178210Senicapoc in Alzheimer's Disease
- University of California, Davis Alzheimer's Disease Center, Sacramento
- UC Davis Alzheimer's Disease Center East Bay, Walnut Creek
Тражи се учесникФаза 2Здраве особе су добродошле
Узраст од 55 до 85 · Оба пола · Ажурирано 17. 8. 2026. · NCT04804241Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digital Testing Platform Across the Lifespan
- The Neurology Center of Southern California, Carlsbad
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 18 до 100 · Оба пола · Ажурирано 17. 8. 2026. · NCT07763392Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- University of California, San Diego (UCSD) - Medical Center, La Jolla
- University of California, Los Angeles (UCLA) - David Geffen School of Medicine, Los Angeles
- University of California, San Francisco (UCSF), San Francisco
- и још 1
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 8. 2026. · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- University of California San Diego Medical Center, La Jolla
- University of Southern Califonria, Los Angeles
Тражи се учесникФаза 2/3Здраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 27. 7. 2026. · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- University of California San Diego Medical Center, La Jolla
- University of Southern Califonria, Los Angeles
Тражи се учесникФаза 2/3Здраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 27. 7. 2026. · NCT05552157A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
- Inland Psychiatric Medical Group., Chino
Тражи се учесникФаза 3
Узраст од 55 до 90 · Оба пола · Ажурирано 30. 6. 2026. · NCT06947941Polyphenols and Cognitive Decline
- University of California, Los Angeles, Los Angeles
Тражи се учесникЗдраве особе су добродошле
Узраст 50 и старији · Оба пола · Ажурирано 11. 6. 2026. · NCT06507254A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- Collaborative Neuroscience Network - CNS, Los Alamitos
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 45 до 85 · Оба пола · Ажурирано 4. 6. 2026. · NCT06657768TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
- Shiley Marcos Alzheimer's Disease Center, San Diego
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст 60 и старији · Оба пола · Ажурирано 26. 5. 2026. · NCT06548191Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.